An integrative pathway-based clinical-genomic model for cancer survival prediction
DOI10.1016/J.SPL.2010.04.011zbMATH Open1198.62158OpenAlexW2026011470WikidataQ42776111 ScholiaQ42776111MaRDI QIDQ988098FDOQ988098
Authors: Xi Chen, Lily Wang, Hemant Ishwaran 
Publication date: 26 August 2010
Published in: Statistics \& Probability Letters (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.spl.2010.04.011
Recommendations
- Survival prediction using gene expression data: a review and comparison
- Survival prediction with gene expression profiles
- Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression
- Bayesian predictive modeling for genomic based personalized treatment selection
- Enhancing the lasso approach for developing a survival prediction model based on gene expression data
Factor analysis and principal components; correspondence analysis (62H25) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Cites Work
- Estimating the number of clusters in a data set via the gap statistic
- Random survival forests
- Variable importance in binary regression trees and forests
- Random forests
- Prediction by Supervised Principal Components
- L 1-Regularization Path Algorithm for Generalized Linear Models
- Efficient quadratic regularization for expression arrays
- Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited
Cited In (16)
- Algorithms for drug sensitivity prediction
- On orthogonal feature extraction model with applications in medical prognosis
- Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression
- Network-based survival analysis to discover target genes for developing cancer immunotherapies and predicting patient survival
- Bayesian Weibull tree models for survival analysis of clinico-genomic data
- Enhancing the lasso approach for developing a survival prediction model based on gene expression data
- Subtype classification and heterogeneous prognosis model construction in precision medicine
- Predicting patient survival from longitudinal gene expression
- Sparse representation-based patient-specific diagnosis and treatment for esophageal squamous cell carcinoma
- Prediction of lung cancer patients' response to combined chemo-radiotherapy using a personalized hybrid model
- PLS-frailty model for cancer survival analysis based on gene expression profiles
- Leveraging external knowledge on molecular interactions in classification methods for risk prediction of patients
- Modeling between-study heterogeneity for improved replicability in gene signature selection and clinical prediction
- A combination model of robust principal component analysis and multiple kernel learning for cancer patient stratification
- A hierarchical Bayesian model for inference of copy number variants and their association to gene expression
- Bayesian predictive modeling for genomic based personalized treatment selection
Uses Software
This page was built for publication: An integrative pathway-based clinical-genomic model for cancer survival prediction
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q988098)
